Jump to the top of the page

Showing 1210 – 1220 of 1299 results

  • Vestis Corporation Initiation

    William Blair initiated research coverage of Vestis Corporation (VSTS $11.65), a leading provider of uniform rental services and workplace supplies across the United States and Canada.

  • Federal Signal Corporation Initiation

    William Blair initiated research coverage of Federal Signal Corporation (FSS $87.25), a manufacturer of specialty commercial vehicles and audio and visual warning equipment for municipal, state, and federal government and industrial end-markets.

  • Proficient Auto Logistics Inc Initiation

    William Blair initiated research coverage of Proficient Auto Logistics, Inc. (PAL $15.13), a leading provider of auto transport services to individuals and businesses throughout the United States.

  • Tenaya Therapeutics Inc Initiation

    William Blair initiated research coverage of Tenaya Therapeutics, Inc. (TNYA $3.67), a clinical-stage, modality-agnostic biotech company focused on the development of potentially curative therapies for rare and prevalent cardiovascular diseases.

  • Tempus AI, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Tempus AI, Inc. (TEM $30.88), a company that provides precision medicine solutions for patients and uses its data platform to offer insights for researchers and pharma companies.

  • Inari Medical Inc Initiation

    William Blair initiated research coverage of Inari Medical, Inc. (NARI $54.73), a medical device company that develops interventional products for patients suffering from venous diseases.

  • Modine Manufacturing Company Initiation

    William Blair initiated research coverage of Modine Manufacturing Company (MOD $99.50). Modine provides thermal management solutions across two segments: climate solutions and performance technologies.

  • Korro Bio Inc Initiation

    William Blair initiated research coverage of Korro Bio, Inc. (KRRO $35.97), a company pioneering ADAR-based RNA-editing therapies for rare diseases with its proprietary OPERA platform.

  • TWFG Inc Initiation

    William Blair initiated research coverage of TWFG, Inc. (TWFG $26.30), an independent distributor of personal and commercial insurance.

  • Solid Biosciences Inc Initiation

    William Blair initiated research coverage of Solid Biosciences Inc. (SLDB $13.57), a development-stage biopharmaceutical company focused on gene therapies for rare neuromuscular and cardiac diseases.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures